罗格列酮治疗2型糖尿病患者发生非致命性心力衰竭风险的meta分析
武珊珊;张渊;孙凤;詹思延
Non-fatal heart failure risk occurring in type 2 diabetic patients receiving rosiglitazone therapy: a metaanalysis
Wu Shanshan;Zhang Yuan;Sun Feng;Zhan Siyan
药物不良反应杂志 . 2011, (3): 147 -6 .